Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma
Public ClinicalTrials.gov record NCT03005418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3 Study for the Evaluation of Safety and Efficacy of Humacyte's ATEV for Vascular Replacement or Reconstruction in Patients With Life or Limb-threatening Vascular Trauma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the use of the Acellular Tissue Engineered Vessel (ATEV) in adults with vascular trauma below the neck who are undergoing vascular reconstructive surgery. There will be an extremity cohort and an torso cohort. All subjects will be implanted with an ATEV as an interposition vessel or bypass using standard vascular surgical techniques. There is no control arm.
Study identification
- NCT ID
- NCT03005418
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2018 (Actual)
- Primary completion
- Sep 19, 2023 (Actual)
- Completion
- May 15, 2026 (Actual)
- Last update posted
- Jul 29, 2026
2018 – 2026
United States locations
- U.S. sites
- 27
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jacob Medical Center at UC San Diego | La Jolla | California | 92037 | — |
| Keck Hospital of University of Southern California (USC) | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Cener | Los Angeles | California | 90048 | — |
| UCI Medical Center | Orange | California | 92868 | — |
| University California, Davis | Sacramento | California | 95817 | — |
| University of California San Diego (UCSD) Medical Center | San Diego | California | 92103 | — |
| Ernest E Moore Shock Trauma Center at Denver Health | Denver | Colorado | 80204 | — |
| UF Health Jacksonville | Jacksonville | Florida | 32209 | — |
| Jackson South Medical Center | Miami | Florida | 33136 | — |
| Ryder Trauma Center | Miami | Florida | 33136 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | — |
| R Adams Cowley Baltimore Shock Trauma | Baltimore | Maryland | 21201 | — |
| Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Saint Louis University (SLU) | St Louis | Missouri | 63110 | — |
| Cooper University Hospital | Camden | New Jersey | 08103 | — |
| Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | — |
| Duke University Hospital | Durham | North Carolina | 27705 | — |
| Atrium Health Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Wake Forest School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Penn Presbyterian Medical Center | Philadelphia | Pennsylvania | 19104 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| The University of Texas - Dell Medical School | Austin | Texas | 78701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03005418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2026 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03005418 live on ClinicalTrials.gov.